Breaking News

FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site

Billingham site to support the manufacture of up to 180 million doses Novavax’ NVX-CoV2373 COVID-19 vaccine candidate.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Diosynth Biotechnologies, a global CDMO for biologics, viral vaccines and viral vectors, welcomed UK Prime Minister Boris Johnson to Teesside at its Billingham site, on February 13 to meet the team working to support the manufacture of Novavax’ NVX-CoV2373 COVID-19 vaccine candidate.   The PM toured the facilities where the antigen component (active ingredient) of Novavax’ NVX-CoV2373 COVID-19 vaccine will be manufactured. Fujifilm has been contracted by Novavax to produce antigen for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters